Stem Cell Banking Market to Record 16.4% CAGR to 2023, Expects Infoholic Research in Its In-Demand Report Available at MarketPublishers.com
19 Dec 2017 • by Natalie Aster
LONDON – Around 500 stem cell banks are functioning from pole to pole, and all banks are currently doing all they can to boost their market share. Stem cell banking finds application in thalassemia, brain palsy, leukemia, autistic disturbance, diabetes, among others. Brain palsy captures the lion’s share of around a quarter of the market amid the different applications. Private stem cell banks are implementing manifold publicizing strategies to enhance their products’ visibility amid people.
The market is propelled by factors like easy technique of isolation of stem cells from the samples, rising childbirth figures, surging awareness about stem cell therapeutics, and the growing potential capacity of stem cell treatment. Meantime, the collaboration amongst the cord blood banks, massive investments and funding, and automation of procedures for the banking of stem cells are opening up opportunities for the market’s growth. Nevertheless, fierce competition, high running costs, changes in regulatory requirements, and high barriers to market entry are the key factors hindering the growth of the sector.
The world stem cell banking market is estimated to gain momentum at a 16.4% CAGR through to 2023.
North America is predicted to the major region in the global stem cell banking market over 2017-2023. APAC and RoW are likely to be the emerging regions, with China, India and Japan being the most attractive destinations.
China Cord Blood, Esperite, Via Cord, CBR Systems, Caladrius Biosciences, Smart Cells, Cryo-Cell, ViaCord, StemCyte, Cryoviva, among others, are the leading players.
In-demand study “Stem Cell Banking Market – Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 2017–2023” created by Infoholic Research provides comprehensive coverage of the market from a global perspective.
It offers details about the use and adoption rate of stem cell banking across various regions. The report limelights key trends, drivers, investments, vertical player’s incentives, government efforts towards the stem cell therapy and banking adoption in the forthcoming years alongside the details of marketed devices. The research report provides information on the key challenges that are expected to influence the growth of the marketplace. Furthermore, the report provides true insights into key business opportunities for key stakeholders to expand their business and boost revenue in the specific verticals. It includes detailed Porter’s 5 force and PEST analyses. The report provides market drivers, restraints, opportunities. The study provides the outlook for the stem cell banking market through 2023.
To find other in-demand research studies by this publisher, visit Infoholic Research page at MarketPublishers.com.